R Squared LTD Ocugen, Inc. Transaction History
R Squared LTD
- $214 Billion
- Q4 2025
A detailed history of R Squared LTD transactions in Ocugen, Inc. stock. As of the latest transaction made, R Squared LTD holds 13,217 shares of OCGN stock, worth $15,728. This represents 0.01% of its overall portfolio holdings.
Number of Shares
13,217Holding current value
$15,728% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding OCGN
# of Institutions
106Shares Held
66.5MCall Options Held
531KPut Options Held
433K-
Black Rock Inc. New York, NY17.9MShares$21.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.5MShares$19.6 Million0.0% of portfolio
-
Ubs Group Ag4.85MShares$5.77 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.16MShares$4.95 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA4.15MShares$4.94 Million0.31% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $258M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...